Press release

Royal DSM and Lallemand conclude license agreement

Elgin IL , US, 05 Apr 2019 08:00 CDT/15:00 CEST

Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, and Lallemand Inc., a leader in the development, production and marketing of yeast, bacteria and specialty ingredients, are pleased to announce a joint agreement under which DSM grants a non-exclusive, royalty bearing license to its low-glycerol yeast technology patents (U.S. Patent No. 8,795,998) to Lallemand.

The license agreement is part of a settlement that was reached following a 2018 US Federal Court jury verdict in Wisconsin.

The referenced technology in the agreement is for use in the fermentation of first-generation biofuels.

For more information

Hugh Welsh

President DSM North America
+1 973 257 8208

This site uses cookies to optimize your user experience.

Read more